Enovis (ENOV)

• Market cap: $2.43B
• 1 day: -2.71%
• 5 days: -3.35%
• 1 month: -11.00%
• 3 months: -7.49%
• 6 months: -3.81%
• Year to date: -3.59%
• 1 year: -29.14%
• 5 years: 9.79%
• 10 years: -17.72%
• Sector: Healthcare
• Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies

About: Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.

Employees: 6,550

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

176% more call options, than puts

Call options by funds: $80.4M | Put options by funds: $29.1M

79% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 71

6% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 48

2% more capital invested

Capital invested by funds: $2.62B [Q3] → $2.68B (+$64.8M) [Q4]

0.44% more ownership

Funds ownership: 108.93% [Q3] → 109.38% (+0.44%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

2% less funds holding

Funds holding: 283 [Q3] → 277 (-6) [Q4]